---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-009282"
form_type: "8-K"
ticker: "NXTC"
cik: "0001661059"
company_name: "NextCure, Inc."
filed_at: "2024-06-18T23:59:59+00:00"
generated_at: "2026-06-01T03:54:56.346913+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# NextCure CMO Han Myint retires July 1; becomes consultant through 2025

## Summary
- Dr. Han Myint retires as CMO effective July 1, 2024; will provide consulting services starting July 2, 2024 on clinical trials and join Scientific Advisory Board.
- The Company will provide continued salary and healthcare benefits through March 31, 2025.
- Equity awards continue to vest during the consulting term; exercisability period extended to 90 days after term expiration.
- Consulting agreement initial term through July 2, 2025, auto-renewing annually unless terminated by either party.

## SEC filing metadata
- accession: 0001558370-24-009282
- form_type: 8-K
- ticker: NXTC
- cik: 0001661059
- company_name: NextCure, Inc.
- filed_at: 2024-06-18T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1661059/000155837024009282/0001558370-24-009282-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1661059/000155837024009282/nxtc-20240618x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-009282
- JSON: https://secwatch.observer/filing/0001558370-24-009282.json
- Plain text: https://secwatch.observer/filing/0001558370-24-009282.txt

## Key facts
- Executive change
  Han Myint retired as Chief Medical Officer at NextCure, Inc..
  - Action: retired
  - Role: Chief Medical Officer
  source text: Dr. Han Myint, M.D. notified NextCure, Inc. (the “Company”) of his plan to retire from his position as Chief Medical Officer of the Company, effective July 1, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1661059/000155837024009282/0001558370-24-009282-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.